Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
Thomas Jefferson University
Thomas Jefferson University
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoag Memorial Hospital Presbyterian
Fred Hutchinson Cancer Center
US Oncology Research
Chiron Corporation